PedAM
Pediatric Disease Annotations & Medicines
| Disease | muscular dystrophy |
| Symptom | C0004093|weakness |
| Sentences | 14 |
| PubMedID- 23472962 | Background: duchenne muscular dystrophy (dmd) leads to progressive muscular weakness and death, most typically from respiratory complications. |
| PubMedID- 25270028 | In 2009, a homozygous mutation was identified in dpm3 in a young woman who presented with muscle weakness due to muscular dystrophy as diagnosed after muscle biopsy and a dilated cardiomyopathy (lefeber et al 2009). |
| PubMedID- 22186027 | This study focused on three non-related pediatric patients exhibiting muscle weakness characteristic of muscular dystrophy. |
| PubMedID- 23453859 | Oculopharyngeal muscular dystrophy as a cause of progression of weakness in antibody positive myasthenia gravis. |
| PubMedID- 22255098 | The arm is intended for people with neuromuscular weakness due to muscular dystrophy or spinal muscular atrophy. |
| PubMedID- 26385658 | Background: persons suffering from progressive muscular weakness, like those with duchenne muscular dystrophy (dmd), gradually lose the ability to stand, walk and to use their arms. |
| PubMedID- 20584890 | Mechanisms of muscle weakness in muscular dystrophy. |
| PubMedID- 23903496 | Parkinson's disease, dystonia and neuromuscular diseases (motor neuron disease, myositis and muscular dystrophy) with weakness of the axial muscles may result in bent spine syndrome and is often combined with a dropped head. |
| PubMedID- 23254335 | The classifications of the dysferlinopathies mainly include limb-girdle muscular dystrophy 2b (lgmd2b) with predominantly proximal weakness, miyoshi myopathy (mm) with calf muscle weakness and atrophy, and distal myopathy with anterior tibial onset (dmat) with tibialis muscle atrophy. |
| PubMedID- 25312642 | Myofiber necrosis and fibrosis are hallmarks of duchenne muscular dystrophy (dmd), leading to lethal weakness of the diaphragm. |
| PubMedID- 23662227 | The muscle weakness mimics that of muscular dystrophy or other muscle disease. |
| PubMedID- 24119284 | Background: although muscle weakness is a hallmark of facioscapulohumeral muscular dystrophy (fshd), the molecular mechanisms that lead to weakness in fshd remain largely unknown. |
| PubMedID- 21565990 | These data indicate that the functional benefits of tat-muutr replacement treatment extend to the mdx:utr(-/-) double-knockout mouse and support its development as a therapy to mitigate muscle weakness in patients with duchenne muscular dystrophy. |
| PubMedID- 24717985 | Facioscapulohumeral muscular dystrophy cases with facial weakness before the age of 5 and signs of shoulder weakness by the age of 10 are defined as early onset. |
Page: 1